Market Research Logo

Europe Market Report Suite for Immunology Drugs 2017 - MedSuite

Europe Market Report Suite for Immunology Drugs 2017 - MedSuite

The Europe immunology drugs report provides market analysis, sizing, forecasts, and market shares of the immunology drugs. The report analyses key factors instrumental in changing the market scenario and provide a forecast of the future immunology market across the major 5 countries in Europe. Key market players are profiled and a detailed view of their current strategic interests and a review on their financial performance has been provided.


REPORT GUIDANCE
MARKET DEFINITION
RESEARCH METHODOLOGY
EXECUTIVE SUMMARY
DISEASE OVERVIEW
Rheumatoid Arthritis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Crohn’s Disease
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Ankylosing Spondylitis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Psoriasis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
Ulcerative Colitis
Introduction
Causes and Disease Progression
Diagnosis and Treatment Options
Symptoms and Complications
Epidemiology
PRODUCT ASSESSMENT
Clinical Trials Overview
Pipeline Analysis
Promising new drugs for Ankylosing Spondylitis in the pipeline
Promising new drugs for Crohn's Disease in the pipeline
Promising new drugs for Psoriasis in the pipeline
Promising new drugs for Rheumatoid Arthritis in the pipeline
Key Marketed Products Portfoilo
Orencia (abatacept)
Humira (adalimumab)
Cimzia (certolizumab)
Enbrel (etanercept)
Benepali (etanercept)
Simponi (golimumab)
Remicade (infliximab) + Remsima/Inflectra (infliximab)
Inflectra (infliximab)
Flixabi (infliximab)
Rituxan (rituximab)
Actemra/RoActemra (toclizumab)
XELJANZ (tofacitnib)
Kineret (anakinra)
Stelara (ustekinumab)
Entyvio (vedolizumab)
Tysabri (natalizumab )
Cosentyx (secukinumab)
Taltz (ixekizumab)
DRUG COST ANALYSIS
EUROPE IMMUNOLOGY MARKET OVERVIEW
Introduction
Currency Exchange Rate
EUROPE IMMUNOLOGY MARKET - BY DISEASES
Market Overview
Rheumatoid Arthritis
Crohn’s Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis
EUROPE IMMUNOLOGY MARKET - BY TREATMENTS
Market Overview
Biologics (Biologic DMARDS)
Non-biologics (corticosteroids, NSAIDs, tDMARDS & other non-biologic)
EUROPE IMMUNOLOGY BIOLOGICS SEGMENT ANALYSIS - BY DRUGS
Rheumatoid Arthritis Drugs
Crohn’s Disease Drugs
Ankylosing Spondylitis Drugs
Psoriasis Drugs
Ulcerative Colitis Drugs
EUROPE IMMUNOLOGY BIOLOGICS SEGMENT ANALYSIS - BY MECHANISM OF ACTION (MOA)
TNF
JFK
Others
COUNTRY PROFILES
United Kingdom
France
Germany
Italy
Spain
Rest of Europe
COMPETITIVE LANDSCAPE
Mergers & Acquisitions
Collaborations & Agreements
Market Shares & Competitive Analysis – by key players
COMPANY PROFILES
AbbVie Inc.
Business Overview
Product Portfoilio
Financials
SWOT Analysis
AstraZeneca Plc
Business Overview
Product Portfoilio
Financials
SWOT Analysis
F. Hoffmann-La Roche Ltd
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Johnson & Johnson
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Merck KGaA
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Novartis AG
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Pfizer Inc.
Business Overview
Product Portfoilio
Financials
SWOT Analysis
Takeda Pharmaceuticals
Business Overview
Product Portfoilio
Financials
SWOT Analysis
UCB S.A.
Business Overview
Product Portfoilio
Financials
SWOT Analysis
FUTURE OUTLOOK OF THE MARKET
ABBREVIATIONS
APPENDIX: PRESS RELEASES
List of Charts:
Europe Immunology Market Size, 2013 - 2023 (US$M)
Europe Immunology Market Size, by Region, 2013 - 2023 (US$M)
Europe Immunology Market, by Diseases, 2013 - 2023 (US$M)
Europe Immunology Market, by Treatment, 2013 - 2023 (US$M)
Europe Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
Europe Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
United Kingdom Immunology Market Size, 2013 - 2023 (US$M)
United Kingdom Immunology Market Size, by Region, 2013 - 2023 (US$M)
United Kingdom Immunology Market, by Diseases, 2013 - 2023 (US$M)
United Kingdom Immunology Market, by Treatment, 2013 - 2023 (US$M)
United Kingdom Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
United Kingdom Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
France Immunology Market Size, 2013 - 2023 (US$M)
France Immunology Market Size, by Region, 2013 - 2023 (US$M)
France Immunology Market, by Diseases, 2013 - 2023 (US$M)
France Immunology Market, by Treatment, 2013 - 2023 (US$M)
France Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
France Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
Germany Immunology Market Size, 2013 - 2023 (US$M)
Germany Immunology Market Size, by Region, 2013 - 2023 (US$M)
Germany Immunology Market, by Diseases, 2013 - 2023 (US$M)
Germany Immunology Market, by Treatment, 2013 - 2023 (US$M)
Germany Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
Germany Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
Italy Immunology Market Size, 2013 - 2023 (US$M)
Italy Immunology Market Size, by Region, 2013 - 2023 (US$M)
Italy Immunology Market, by Diseases, 2013 - 2023 (US$M)
Italy Immunology Market, by Treatment, 2013 - 2023 (US$M)
Italy Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
Italy Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
Spain Immunology Market Size, 2013 - 2023 (US$M)
Spain Immunology Market Size, by Region, 2013 - 2023 (US$M)
Spain Immunology Market, by Diseases, 2013 - 2023 (US$M)
Spain Immunology Market, by Treatment, 2013 - 2023 (US$M)
Spain Immunology Market, by Biologic DMARDs, 2013 - 2023 (US$M)
Spain Immunology Market, by Biologic DMARDs - Mechanism of Action (MOA), 2013 - 2023 (US$M)
List of Figures
Figure 1: Overview of Diseases
Figure 2: Overview of symptoms and diagnosis of key diseases
Figure 3: Prevalence of key Immunological disorders
Figure 4: List of pipeline drugs,
Figure 5: List of key clinical trials of promising products
Figure 6: List of marketed products by key players
Figure 7: Average selling price analysis of key marketed drugs
Figure 8: Clinical trials of immunology drugs, Phase 3,
Figure 9: List of Mergers & Acquisitions, 2015 to
Figure 10: List of Collaborations & Agreements, 2015 to
Figure 11: List of marketed products by key players
Figure 12: Market Shares of Immunology Drugs Market, by Treatment,
Figure 13: Market Shares of Immunology Drugs Market, by Drugs,
Figure 14: Market Shares of Immunology Drugs Market, by Target Molecule
Figure 15: Market Shares of Immunology Drugs Market, by Geography,
Figure 16: Market Shares of Immunology Drugs Market, by Key Companies,

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report